GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » LSL Pharma Group Inc (TSXV:LSL) » Definitions » Accumulated other comprehensive income (loss)

LSL Pharma Group (TSXV:LSL) Accumulated other comprehensive income (loss) : C$0.00 Mil (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is LSL Pharma Group Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. LSL Pharma Group's Accumulated other comprehensive income (loss) for the quarter that ended in Sep. 2024 was C$0.00 Mil.

LSL Pharma Group Accumulated other comprehensive income (loss) Historical Data

The historical data trend for LSL Pharma Group's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LSL Pharma Group Accumulated other comprehensive income (loss) Chart

LSL Pharma Group Annual Data
Trend Sep20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
- - - -

LSL Pharma Group Quarterly Data
Sep20 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

LSL Pharma Group Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

LSL Pharma Group Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of LSL Pharma Group's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

LSL Pharma Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » LSL Pharma Group Inc (TSXV:LSL) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
XCNQ:VEXT TSXV:DB XCNQ:GWAY XCNQ:BNXT TSX:XLY TSX:AVCN NEOE:CBST XCNQ:IAN XCNQ:LEEF XCNQ:CXXI ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA NSE:DIVISLAB XSWX:SDZ VTRS
Traded in Other Exchanges
N/A
Address
540 d’Avaugour Street, Suite 1800, Boucherville, QC, CAN, J4B 0G6
Website
https://www.laboratoirelsl.com
LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.

LSL Pharma Group Headlines

No Headlines